AMGN Amgen Inc

Price (delayed)

$283.51

Market cap

$151.94B

P/E Ratio

22.57

Dividend/share

$8.64

EPS

$12.56

Enterprise value

$205.61B

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. ...

Highlights
The revenue has grown by 7% year-on-year and by 5% since the previous quarter
Amgen's equity has soared by 70% YoY but it has decreased by 19% from the previous quarter
AMGN's quick ratio has dropped by 59% since the previous quarter but it is up by 4.2% year-on-year
The debt has surged by 66% year-on-year and by 7% since the previous quarter
The P/E is 23% above the last 4 quarters average of 18.3 and 18% above the 5-year quarterly average of 19.1

Key stats

What are the main financial stats of AMGN
Market
Shares outstanding
535.92M
Market cap
$151.94B
Enterprise value
$205.61B
Valuations
Price to book (P/B)
24.35
Price to sales (P/S)
5.38
EV/EBIT
19.16
EV/EBITDA
13.89
EV/Sales
7.29
Earnings
Revenue
$28.19B
EBIT
$10.73B
EBITDA
$14.8B
Free cash flow
$7.36B
Per share
EPS
$12.56
Free cash flow per share
$13.76
Book value per share
$11.64
Revenue per share
$52.69
TBVPS
$85.76
Balance sheet
Total assets
$97.15B
Total liabilities
$90.92B
Debt
$64.61B
Equity
$6.23B
Working capital
$11.94B
Liquidity
Debt to equity
10.37
Current ratio
1.65
Quick ratio
0.99
Net debt/EBITDA
3.63
Margins
EBITDA margin
52.5%
Gross margin
70%
Net margin
23.8%
Operating margin
28%
Efficiency
Return on assets
7.3%
Return on equity
103.3%
Return on invested capital
14.5%
Return on capital employed
13.6%
Return on sales
38.1%
Dividend
Dividend yield
3.05%
DPS
$8.64
Payout ratio
68.8%

AMGN stock price

How has the Amgen stock price performed over time
Intraday
-0.07%
1 week
-2.4%
1 month
-7.89%
1 year
17.87%
YTD
-1.57%
QTD
-1.57%

Financial performance

How have Amgen's revenue and profit performed over time
Revenue
$28.19B
Gross profit
$19.74B
Operating income
$7.9B
Net income
$6.72B
Gross margin
70%
Net margin
23.8%
The company's operating margin fell by 23% YoY and by 15% QoQ
AMGN's operating income is down by 17% year-on-year and by 11% since the previous quarter
The net margin has declined by 16% since the previous quarter and by 4.4% year-on-year
The net income has contracted by 11% from the previous quarter but it has grown by 2.5% YoY

Growth

What is Amgen's growth rate over time

Valuation

What is Amgen stock price valuation
P/E
22.57
P/B
24.35
P/S
5.38
EV/EBIT
19.16
EV/EBITDA
13.89
EV/Sales
7.29
The P/E is 23% above the last 4 quarters average of 18.3 and 18% above the 5-year quarterly average of 19.1
AMGN's EPS is down by 11% since the previous quarter but it is up by 3.1% year-on-year
Amgen's equity has soared by 70% YoY but it has decreased by 19% from the previous quarter
The stock's price to book (P/B) is 14% more than its last 4 quarters average of 21.3 but 7% less than its 5-year quarterly average of 26.2
The revenue has grown by 7% year-on-year and by 5% since the previous quarter
The P/S is 5% more than the last 4 quarters average of 5.1 and 3.5% more than the 5-year quarterly average of 5.2

Efficiency

How efficient is Amgen business performance
The ROE has plunged by 58% YoY and by 20% from the previous quarter
AMGN's return on assets is down by 31% year-on-year and by 19% since the previous quarter
The ROIC has contracted by 19% YoY and by 15% from the previous quarter
AMGN's return on sales is up by 15% year-on-year but it is down by 9% since the previous quarter

Dividends

What is AMGN's dividend history
DPS
$8.64
Dividend yield
3.05%
Payout ratio
68.8%
Recent dividends

Financial health

How did Amgen financials performed over time
Amgen's total assets is 7% more than its total liabilities
AMGN's quick ratio has dropped by 59% since the previous quarter but it is up by 4.2% year-on-year
Amgen's total assets has increased by 49% YoY and by 7% from the previous quarter
Amgen's equity has soared by 70% YoY but it has decreased by 19% from the previous quarter
The debt has surged by 66% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.